Knockdown of GA-binding protein subunit β1 inhibits cell proliferation via p21 induction in renal cell carcinoma.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  International Journal of Oncology

• Publication date

  2018-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ijo.2018.4411PMID 29845229
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neural Field Continuum Limits and the Structure–Function Partitioning of Cognitive–Emotional Brain Networks

  2023cited by this paper
• Long noncoding RNA-SRLR elicits intrinsic sorafenib resistance via evoking IL-6/STAT3 axis in renal cell carcinoma

  2017cited by this paper
• DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis

  2017cited by this paper
• In silico identification of potential key regulatory factors in smoking-induced lung cancer

  2017cited by this paper
• SDHD Promoter Mutations Ablate GABP Transcription Factor Binding in Melanoma.

  2017cited by this paper
• Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p

  2016cited by this paper
• The Gene Expression Omnibus Database

  2016cited by this paper
• Expression of the ETS transcription factor GABPα is positively correlated to the BCR-ABL1/ABL1 ratio in CML patients and affects imatinib sensitivity in vitro.

  2015cited by this paper
• Suppression of PGC-1α Is Critical for Reprogramming Oxidative Metabolism in Renal Cell Carcinoma.

  2015cited by this paper
• The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer

  2015cited by this paper
• Commentary: The unliganded glucocorticoid receptor positively regulates the tumor suppressor gene BRCA1 through GABP beta

  2015cited by this paper
• Cancer treatment and survivorship statistics, 2014

  2014cited by this paper
• LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures

  2014cited by this paper
• TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

  2013cited by this paper
• The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense.

  2013cited by this paper
• Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.

  2013cited by this paper
• SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis

  2013cited by this paper
• Significance of Heparanase in Cancer and Inflammation

  2012cited by this paper
• The Unliganded Glucocorticoid Receptor Positively Regulates the Tumor Suppressor Gene BRCA1 through GABP Beta

  2012cited by this paper
• Cancer treatment and survivorship statistics, 2012

  2012cited by this paper
• Induction of heparanase-1 expression by mutant B-Raf kinase: role of GA binding protein in heparanase-1 promoter activation.

  2010cited by this paper
• GABP transcription factor is required for myeloid differentiation, in part, through its control of Gfi-1 expression.

  2010cited by this paper
• Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response.

  2010cited by this paper
• Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.

  2009cited by this paper
• p21 in cancer: intricate networks and multiple activities

  2009cited by this paper
• Resistance to targeted therapy in renal-cell carcinoma.

  2009cited by this paper
• Renal cell carcinoma

  2009cited by this paper
• Treatment options for metastatic renal cell carcinoma: a review.

  2008influential reference
• Hematopoiesis: an evolving paradigm for stem cell biology.

  2008cited by this paper
• Candidate biomarkers in renal cell carcinoma

  2007cited by this paper
• Secreted Frizzled-Related Protein 1 Loss Contributes to Tumor Phenotype of Clear Cell Renal Cell Carcinoma

  2007cited by this paper
• The transcription factor GABP is a critical regulator of B lymphocyte development.

  2007cited by this paper
• The Ets transcription factor GABP is required for cell-cycle progression

  2007cited by this paper
• Renal cell carcinoma

  2006cited by this paper
• Stabilization of disease in patients with metastatic renal cell carcinoma using sorafenib

  2006cited by this paper
• Cyclin-dependent kinase pathways as targets for cancer treatment.

  2006cited by this paper
• Gene Signatures of Progression and Metastasis in Renal Cell Cancer

  2005cited by this paper
• Renal cell carcinoma: etiology, incidence and epidemiology

  2004cited by this paper
• Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma.

  2004cited by this paper
• GA-binding protein transcription factor: a review of GABP as an integrator of intracellular signaling and protein-protein interactions.

  2004cited by this paper
• ONCOMINE: a cancer microarray database and integrated data-mining platform.

  2004cited by this paper
• GA binding protein regulates interleukin 7 receptor alpha-chain gene expression in T cells.

  2004cited by this paper
• Ets proteins in biological control and cancer

  2004cited by this paper
• The basement membrane matrix in malignancy

  2003cited by this paper
• An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.

  2002cited by this paper
• Cloning and Characterization of the Human Heparanase-1 (HPR1) Gene Promoter

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Heparanase: Breaking down barriers in tumors

  1999cited by this paper
• A survey of telomerase activity in human cancer.

  1997cited by this paper
• Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl

  1997cited by this paper
• 4. Modelling Survival Data in Medical Research

  1995cited by this paper
• Identification of Ets- and notch-related subunits in GA binding protein.

  1991cited by this paper

• GABPB1 activates transcription of ITPR3 and EMT in OSCC progression

  2026cites this paper
• GABPB1 plays a cancer-promoting role in non-small cell lung cancer

  2024cites this paper
• BAIAP2L2 promotes the malignancy of hepatocellular carcinoma via GABPB1-mediated reactive oxygen species imbalance

  2024cites this paper
• Genome-wide Detection of Chimeric Transcripts in Early-stage Non-small Cell Lung Cancer

  2023cites this paper
• RALY regulate the proliferation and expression of immune/inflammatory response genes via alternative splicing of FOS

  2022cites this paper
• Small RNA sequencing and identification of papaya (Carica papaya L.) miRNAs with potential cross-kingdom human gene targets

  2022cites this paper
• BAIAP2L2 is activated by NFκB1 and promotes the malignancy of hepatocellular carcinoma by suppressing the ubiquitin-mediated degradation of GABPB1 to activate TRET transcription

  2022cites this paper
• Canine Oral Melanoma Genomic and Transcriptomic Study Defines Two Molecular Subgroups with Different Therapeutical Targets

  2021cites this paper
• OTT_A_257275 6827..6836

  2020cites this paper
• LncRNA GA-Binding Protein Transcription Factor Subunit Beta-1 Antisense RNA 1 Inhibits Renal Carcinoma Growth Through an MiR-1246/Phosphoenolpyruvate Carboxykinase 1 Pathway

  2020cites this paper
• LncRNA CALML3-AS1 promotes tumorigenesis of bladder cancer via regulating ZBTB2 by suppression of microRNA-4316.

  2018cites this paper